Candesartan HCT 32-25mg Tablets

Manufacturer SOLCO HEALTHCARE Active Ingredient Candesartan and Hydrochlorothiazide(kan de SAR tan & hye droe klor oh THYE a zide) Pronunciation KAN-de-sar-tan H-C-T (kan de SAR tan & hye droe klor oh THYE a zide)
WARNING: Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away. @ COMMON USES: It is used to treat high blood pressure.
🏷️
Drug Class
Antihypertensive, Angiotensin Receptor Blocker (ARB) / Thiazide Diuretic Combination
🧬
Pharmacologic Class
Angiotensin II Receptor Blocker; Thiazide Diuretic
🤰
Pregnancy Category
Category X
FDA Approved
Apr 1998
⚖️
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

This medication is a combination of two drugs: Candesartan and Hydrochlorothiazide. Candesartan helps relax blood vessels, and Hydrochlorothiazide helps your body get rid of extra salt and water. Together, they work to lower your blood pressure, which can help prevent strokes, heart attacks, and kidney problems.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. You can take this medication with or without food. Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel well.

It's essential to drink plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake. Be aware that this medication may increase your urine production, so try to avoid taking it too close to bedtime to minimize sleep disturbances.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, avoiding the bathroom. Keep all medications in a safe location, out of the reach of children and pets. When disposing of unused or expired medication, do not flush it down the toilet or pour it down the drain unless instructed to do so by your doctor or pharmacist. Instead, check with your pharmacist for guidance on the best disposal method or explore local drug take-back programs.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
💡

Lifestyle & Tips

  • Take this medication exactly as prescribed, usually once daily with or without food.
  • Do not stop taking this medication without talking to your doctor, even if you feel well.
  • Continue to monitor your blood pressure regularly at home as advised by your doctor.
  • Limit your intake of high-sodium foods (salt) as directed by your doctor or dietitian.
  • Maintain a healthy diet rich in fruits, vegetables, and whole grains.
  • Engage in regular physical activity as recommended by your doctor.
  • Limit alcohol consumption.
  • Avoid potassium supplements or salt substitutes containing potassium unless specifically instructed by your doctor.
  • Stay well-hydrated, especially during exercise or hot weather, but avoid excessive fluid intake unless advised by your doctor.

Dosing & Administration

👨‍⚕️

Adult Dosing

Standard Dose: One tablet (Candesartan 32mg / HCTZ 25mg) orally once daily. This strength is typically used for patients whose blood pressure is not adequately controlled with Candesartan 32mg or HCTZ 25mg alone, or with lower combination strengths.

Condition-Specific Dosing:

hypertension: Initial dose typically Candesartan 16mg/HCTZ 12.5mg once daily, titrate up to 32mg/25mg as needed for blood pressure control. The 32mg/25mg strength is a maximum dose for most patients.
👶

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
⚕️

Dose Adjustments

Renal Impairment:

Mild: No initial dose adjustment needed (CrCl > 50 mL/min).
Moderate: Use with caution (CrCl 30-50 mL/min). Lower initial doses of Candesartan (e.g., 8mg) may be considered. Hydrochlorothiazide efficacy decreases significantly below CrCl 30 mL/min.
Severe: Contraindicated (CrCl < 30 mL/min) due to the hydrochlorothiazide component. Candesartan alone requires dose adjustment.
Dialysis: Contraindicated. Candesartan is not dialyzable. Hydrochlorothiazide is not effective in severe renal impairment.

Hepatic Impairment:

Mild: No initial dose adjustment needed.
Moderate: Use with caution. Candesartan exposure may be increased. Hydrochlorothiazide is primarily renally eliminated.
Severe: Not recommended. No specific dosing guidelines, but increased risk of adverse effects.

Pharmacology

🔬

Mechanism of Action

Candesartan cilexetil is a prodrug that is rapidly converted to candesartan during absorption from the gastrointestinal tract. Candesartan is an angiotensin II receptor blocker (ARB) that selectively blocks the binding of angiotensin II to the AT1 receptor in many tissues, including vascular smooth muscle and the adrenal gland. This blockade inhibits the vasoconstrictive and aldosterone-secreting effects of angiotensin II, leading to vasodilation, decreased peripheral resistance, and reduced blood pressure. Hydrochlorothiazide is a thiazide diuretic that acts on the distal convoluted tubule of the kidney to inhibit the reabsorption of sodium and chloride ions. This increases the excretion of sodium, chloride, and water, leading to a reduction in plasma volume and blood pressure. The combination provides additive antihypertensive effects.
📊

Pharmacokinetics

Absorption:

Bioavailability: Candesartan: ~15% (as candesartan from candesartan cilexetil); Hydrochlorothiazide: 50-80%
Tmax: Candesartan: 3-4 hours; Hydrochlorothiazide: 1-2.5 hours
FoodEffect: Candesartan: Minimal effect on bioavailability; Hydrochlorothiazide: Increases absorption slightly, but not clinically significant.

Distribution:

Vd: Candesartan: 0.13 L/kg; Hydrochlorothiazide: 0.8 L/kg
ProteinBinding: Candesartan: >99%; Hydrochlorothiazide: 40-60%
CnssPenetration: Limited

Elimination:

HalfLife: Candesartan: ~9 hours; Hydrochlorothiazide: 5.6-14.8 hours
Clearance: Candesartan: ~0.37 mL/min/kg; Hydrochlorothiazide: ~2.5-3.0 mL/min/kg
ExcretionRoute: Candesartan: Renal (33%) and biliary/fecal (67%); Hydrochlorothiazide: Primarily renal (95% unchanged)
Unchanged: Candesartan: ~33% (renal); Hydrochlorothiazide: ~95% (renal)
⏱️

Pharmacodynamics

OnsetOfAction: Candesartan: Within 2 hours; Hydrochlorothiazide: Within 2 hours
PeakEffect: Candesartan: 4-8 hours; Hydrochlorothiazide: 4-6 hours
DurationOfAction: Candesartan: 24 hours; Hydrochlorothiazide: 6-12 hours

Safety & Warnings

⚠️

BLACK BOX WARNING

When pregnancy is detected, discontinue Candesartan HCTZ as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.
⚠️

Side Effects

Serious Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion
+ Feeling sleepy
+ Unusual thirst or hunger
+ Passing urine more often
+ Flushing
+ Fast breathing
+ Breath that smells like fruit
Signs of fluid and electrolyte problems, such as:
+ Mood changes
+ Confusion
+ Muscle pain or weakness
+ Fast or abnormal heartbeat
+ Severe dizziness or passing out
+ Increased thirst
+ Seizures
+ Feeling very tired or weak
+ Decreased appetite
+ Unable to pass urine or change in the amount of urine produced
+ Dry mouth
+ Dry eyes
+ Severe upset stomach or throwing up
Signs of kidney problems, including:
+ Unable to pass urine
+ Change in how much urine is passed
+ Blood in the urine
+ A big weight gain
Signs of lupus, such as:
+ A rash on the cheeks or other body parts
+ Sunburn easy
+ Muscle or joint pain
+ Chest pain or shortness of breath
+ Swelling in the arms or legs
Eye problems, which can lead to lasting eyesight loss if left untreated. If you experience any of the following symptoms, contact your doctor right away:
+ Change in eyesight
+ Eye pain (usually occurring within hours to weeks of starting this medication)
Rarely, certain types of skin cancer have been reported in people taking hydrochlorothiazide. To minimize your risk:
+ Protect your skin from the sun
+ Have your skin checked as directed by your doctor
+ Contact your doctor immediately if you notice any changes in the color or size of a mole, or any new or changing skin lump or growth

Other Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to contact your doctor or seek medical help if you notice any of the following:

Signs of a common cold
Back pain
Flu-like symptoms
* Dizziness

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe dizziness or fainting (especially when standing up)
  • Unusual tiredness or weakness
  • Muscle cramps or pain
  • Nausea, vomiting, or diarrhea that is severe or persistent
  • Swelling of the face, lips, tongue, or throat (signs of a severe allergic reaction called angioedema)
  • Difficulty breathing or swallowing
  • Decreased urination
  • Yellowing of the skin or eyes (jaundice)
  • Unexplained joint pain or swelling (signs of gout)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions to ensure safe treatment:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced.
A known sulfa allergy.
Current treatment with dofetilide.
Inability to urinate.
Kidney disease or kidney problems.
High calcium levels in your blood.
* Use of a medication containing aliskiren, especially if you have diabetes or kidney problems.

Additionally, if you are breast-feeding or plan to breast-feed, you should discuss this with your doctor.

This list is not exhaustive, and it is crucial to disclose all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health issues, to your doctor and pharmacist. They will help determine if it is safe to take this medication with your other treatments and health conditions. Never start, stop, or adjust the dose of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Until you know how this medication affects you, avoid driving and other tasks that require alertness. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying down position, and be cautious when climbing stairs.

Managing Diabetes and Blood Pressure
If you have diabetes, this medication may increase your blood sugar levels. Consult your doctor about maintaining control over your blood sugar. Additionally, monitor your blood pressure as directed by your doctor, and undergo regular blood tests and other laboratory tests as recommended.

Potential Side Effects
This medication may cause elevated cholesterol and triglyceride levels. Discuss this with your doctor. It may also affect certain laboratory test results, so inform all your healthcare providers and laboratory personnel that you are taking this medication.

Interactions with Other Substances
If you are taking a salt substitute containing potassium, a potassium-sparing diuretic, or a potassium product, consult your doctor. Similarly, if you are on a low-salt or salt-free diet, discuss this with your doctor. Before using over-the-counter (OTC) products that may increase blood pressure, such as cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, or certain natural products, consult your doctor.

Precautions with Other Medications and Substances
Before consuming alcohol, marijuana, or other forms of cannabis, or using prescription or OTC medications that may slow your reactions, consult your doctor.

Staying Safe in Hot Weather
Be cautious in hot weather or during physical activity, and drink plenty of fluids to prevent dehydration. If you experience excessive sweating, fluid loss, vomiting, or diarrhea, inform your doctor, as these symptoms may lead to low blood pressure.

Interactions with Other Medications
If you take cholestyramine or colestipol, consult your pharmacist about how to take these medications with this drug. Be aware of the potential for gout attacks.

Special Considerations
If you have lupus, this medication may reactivate or worsen your condition. Inform your doctor immediately if you experience any new or worsening symptoms. It may take up to 1 month to feel the full effects of this medication.
🆘

Overdose Information

Overdose Symptoms:

  • Severe hypotension (very low blood pressure)
  • Dizziness, lightheadedness, fainting
  • Tachycardia (rapid heart rate)
  • Bradycardia (slow heart rate)
  • Electrolyte imbalances (e.g., severe hypokalemia, hyponatremia)
  • Dehydration
  • Nausea, vomiting

What to Do:

Seek immediate medical attention. Call 911 or your local emergency number. For poison control, call 1-800-222-1222. Treatment is supportive and symptomatic, focusing on blood pressure stabilization and correction of electrolyte imbalances.

Drug Interactions

🚫

Contraindicated Interactions

  • Aliskiren (in patients with diabetes or moderate-to-severe renal impairment)
  • Concomitant use with ACE inhibitors or other ARBs (in patients with diabetic nephropathy)
🔴

Major Interactions

  • Lithium (increased serum lithium levels and toxicity)
  • NSAIDs (including COX-2 inhibitors) (reduced antihypertensive effect, increased risk of renal impairment, hyperkalemia)
  • Potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride) (increased risk of hyperkalemia)
  • Potassium supplements (increased risk of hyperkalemia)
  • Other antihypertensive agents (additive hypotensive effects)
  • Drugs that cause hyperkalemia (e.g., trimethoprim, cyclosporine, heparin)
  • Digitalis glycosides (increased risk of digitalis toxicity due to hypokalemia/hypomagnesemia from HCTZ)
  • Corticosteroids, ACTH (enhanced electrolyte depletion, particularly hypokalemia)
  • Antidiabetic agents (oral agents and insulin) (HCTZ may decrease glucose tolerance, requiring dose adjustment of antidiabetic agents)
🟡

Moderate Interactions

  • Cholestyramine, Colestipol (reduced absorption of HCTZ)
  • Pressor amines (e.g., norepinephrine) (HCTZ may decrease arterial responsiveness to pressor amines)
  • Skeletal muscle relaxants, non-depolarizing (e.g., tubocurarine) (HCTZ may potentiate their effect)
  • Barbiturates, Narcotics, Alcohol (may potentiate orthostatic hypotension)
  • Allopurinol (increased risk of hypersensitivity reactions with HCTZ)
  • Calcium salts (increased serum calcium levels due to decreased excretion by HCTZ)
  • Cyclosporine (increased risk of hyperuricemia and gouty complications with HCTZ)
🟢

Minor Interactions

  • None specifically categorized as minor with significant clinical impact for this combination beyond general caution.

Monitoring

🔬

Baseline Monitoring

Blood Pressure (BP)

Rationale: To establish baseline and guide therapy.

Timing: Prior to initiation

Serum Electrolytes (Potassium, Sodium, Magnesium, Calcium)

Rationale: To assess baseline electrolyte status, as both components can affect levels (Candesartan: hyperkalemia risk; HCTZ: hypokalemia, hyponatremia, hypomagnesemia, hypercalcemia).

Timing: Prior to initiation

Renal Function (Serum Creatinine, BUN, eGFR)

Rationale: To assess baseline kidney function, as both drugs are renally eliminated and can affect renal function, especially in susceptible patients.

Timing: Prior to initiation

Liver Function Tests (ALT, AST, Bilirubin)

Rationale: To assess baseline liver function, as Candesartan is metabolized in the liver and hepatic impairment may alter pharmacokinetics.

Timing: Prior to initiation

Serum Uric Acid

Rationale: HCTZ can increase uric acid levels, potentially precipitating gout.

Timing: Prior to initiation

Blood Glucose

Rationale: HCTZ can cause hyperglycemia.

Timing: Prior to initiation

📊

Routine Monitoring

Blood Pressure (BP)

Frequency: Regularly (e.g., weekly after initiation/dose change, then monthly/quarterly)

Target: <130/80 mmHg (or individualized target)

Action Threshold: Persistent elevation above target or symptomatic hypotension

Serum Electrolytes (Potassium, Sodium)

Frequency: 1-2 weeks after initiation/dose change, then every 3-6 months, or as clinically indicated.

Target: Potassium: 3.5-5.0 mEq/L; Sodium: 135-145 mEq/L

Action Threshold: Potassium <3.0 or >5.5 mEq/L; Sodium <130 or >150 mEq/L, or symptomatic changes

Renal Function (Serum Creatinine, eGFR)

Frequency: 1-2 weeks after initiation/dose change, then every 3-6 months, or as clinically indicated.

Target: Stable creatinine, eGFR >60 mL/min/1.73m²

Action Threshold: Increase in creatinine >30% from baseline, or significant decrease in eGFR

Serum Uric Acid

Frequency: Periodically, especially if history of gout or symptoms develop.

Target: Within normal limits

Action Threshold: Significant increase or symptoms of gout

Blood Glucose

Frequency: Periodically, especially in diabetic patients or those at risk.

Target: Individualized based on diabetes status

Action Threshold: Significant increase in glucose levels

👁️

Symptom Monitoring

  • Dizziness or lightheadedness (especially upon standing)
  • Excessive fatigue or weakness
  • Muscle cramps or weakness
  • Nausea or vomiting
  • Dry mouth, increased thirst
  • Swelling of face, lips, tongue, or throat (signs of angioedema)
  • Difficulty breathing or swallowing
  • Signs of dehydration (e.g., decreased urination, severe dry mouth)
  • Symptoms of gout (joint pain, swelling)

Special Patient Groups

🤰

Pregnancy

Contraindicated during pregnancy. Candesartan, an ARB, can cause fetal injury and death when administered to pregnant women. Hydrochlorothiazide can cross the placental barrier and may cause fetal or neonatal jaundice, thrombocytopenia, and possibly other adverse reactions.

Trimester-Specific Risks:

First Trimester: While risks are lower than in later trimesters, exposure to ARBs during the first trimester is associated with an increased risk of major congenital malformations. Discontinue as soon as pregnancy is detected.
Second Trimester: Significant risk of fetal injury and death, including fetal renal dysfunction, oligohydramnios, fetal lung hypoplasia, skeletal deformations, and death.
Third Trimester: Highest risk of severe fetal injury and death, including renal failure, anuria, hypotension, and skull hypoplasia.
🤱

Lactation

Not recommended during breastfeeding. Candesartan is excreted in the milk of lactating rats, and it is unknown if it is excreted in human milk. Hydrochlorothiazide is excreted in human milk and can suppress lactation. Due to the potential for serious adverse reactions in breastfed infants, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Infant Risk: Risk of hypotension, hyperkalemia (from candesartan), and electrolyte disturbances, jaundice, thrombocytopenia (from HCTZ) in the infant. Potential for suppression of lactation.
👶

Pediatric Use

Safety and effectiveness have not been established in pediatric patients. Use is generally not recommended.

👴

Geriatric Use

No overall differences in effectiveness or safety have been observed between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Elderly patients may be more susceptible to volume depletion and electrolyte imbalances (especially hypokalemia) with hydrochlorothiazide. Renal function should be monitored closely, and lower initial doses may be considered.

Clinical Information

💎

Clinical Pearls

  • This combination is particularly useful for patients whose blood pressure is not adequately controlled with monotherapy (either an ARB or a thiazide diuretic alone).
  • Advise patients to report any signs of angioedema (swelling of face, lips, tongue, throat) immediately, as this is a rare but serious side effect.
  • Educate patients on the importance of regular blood pressure monitoring and adherence to medication, even if asymptomatic.
  • Caution patients about orthostatic hypotension, especially at the start of therapy, with dose increases, or when standing up quickly.
  • Remind patients that this medication is not a cure for high blood pressure but helps manage it. Lifestyle modifications remain crucial.
  • Monitor for signs of electrolyte imbalance, particularly hypokalemia (muscle cramps, weakness) and hyperkalemia (fatigue, weakness, irregular heartbeat), and hyponatremia (nausea, headache, confusion).
🔄

Alternative Therapies

  • Other classes of antihypertensives (e.g., ACE inhibitors, Calcium Channel Blockers, Beta-blockers, other diuretics)
  • Monotherapy with Candesartan or Hydrochlorothiazide if blood pressure is adequately controlled.
💰

Cost & Coverage

Average Cost: $15 - $100+ per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (generic)
📚

General Drug Facts

If your symptoms or health condition do not improve or worsen over time, it is essential to contact your doctor for further evaluation and guidance. To ensure safe and effective treatment, never share your medication with others or take medication prescribed to someone else. Some medications may have additional patient information leaflets, so it is a good idea to consult with your pharmacist for more information. If you have any questions or concerns about your medication, do not hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide detailed information, including the name of the medication taken, the amount, and the time it occurred.